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The elongation phase of transcription lies at the core of several simultaneous and coupled events leading to alternative splicing
regulation. Although underestimated in the past, it is at this phase of the transcription cycle where complexes aﬀecting the
transcription machinery itself, chromatin structure, posttranscriptional gene regulation and pre-mRNA processing converge to
regulate each other or simply to consolidate higher-order complexes and functions. This paper focuses on the multiple processes
that take place during transcription elongation which ultimately regulate the outcome of alternative splicing decisions.
1.Introduction
Regulation of gene expression was originally conceived as
a hierarchy of steps linked together on a time scale and phys-
ically separated in diﬀerent cell compartments in accordance
with the central dogma of biology. This concept has long
beenabandoned,withasigniﬁcantaccumulationofevidence
describing an extensive network of events, encompassing
transcription, mRNA processing, chromatin regulation, and
posttranscriptional gene regulation, which take place simul-
taneously and in a mutually regulated or coupled manner
[1, 2]. Distinctions between complexes and processes gov-
erning gene expression have been blurred to a large extent,
adding complexity to the ever-increasing fraction of genes
subjected to alternative promoter usage, alternative splicing
(AS) (>90% genes), alternative polyadenylation, editing, and
posttranscriptional gene silencing by small RNAs [3, 4].
Additionally, this complexity takes a new dimension when
studied in the context of chromatin and its regulation upon
geneexpression(forreviews,see[5–7]).Thispaperwillfocus
on the main features of coupling between transcriptions
elongation and splicing, and its implications on AS regula-
tion.
2. The Beneﬁts of Coupling
Initial visualization of Drosophila-embryo nascent tran-
scripts by electron microscopy, showed that splicing can
occur cotranscriptionally [8]. This was later directly demon-
strated for the human dystrophin gene [9], which spans
2400kb and can take 16hr to complete transcription. More
recently, a quantitative study of the c-Src and ﬁbronectin
mRNAs compared chromatin-bound and nucleoplasmic
RNA fractions. There, it was shown that most introns are
excised eﬃciently in the chromatin-bound fractions, with
a gradient of cotranscriptional splicing eﬃciency decreasing
from promoter-proximal to promoter-distal introns, that is,
the direction of transcription [10].
One implication of the cotranscriptional nature of splic-
ing is that the two processes canbe coupled. In abroadsense,
coupling implies that the involved processes can happen
eﬃciently only as the result of their combined action, even2 Genetics Research International
for processes that are constitutive and non-regulated. For
instance, whereas both transcription and splicing can take
place independently at low eﬃciency as in vitro reactions, it
is only in vivo or in coupled in vitro systems where maximal
eﬃciency can be achieved [11–16]. Cotranscriptional pro-
cessing is necessary to allow for coupling between transcrip-
tion and splicing, although it does not necessarily guarantee
it. There are examples of both cotranscriptional splicing that
s e e m st ob eu n c o u p l e d ,a sw e l la sp u r e l yp o s t t r a n s c r i p t i o n a l
splicing [17–20]. Noteworthy, the consequences of the
diﬀerent types of splicing can be considerable; whereas
cotranscriptional splicing can be regulated by mechanisms
dependent on transcription, postranscriptional splicing can
be subjected to additional regulatory mechanisms linked to
events downstream of transcription (e.g., RNA export) [20].
However, cotranscriptional splicing seems to predominate
for most introns in mammalian genes [10, 17, 20–23]
pointing at an evolutionary conserved role in allowing for
coupling of transcription and splicing. Cotranscriptional
splicing is more eﬃcient than posttranscriptional splicing
by driving nascent pre-mRNAs to the association with
spliceosome components [24, 25] and splicing regulatory
factors, such as serine/arginine-rich (SR) proteins [22]. This
allows for diﬀerent levels of regulation of AS and prevents
backhybridization of the nascent pre-mRNA to the DNA
templatestrand,whichcancausegenomeinstability[26,27].
Even in the case of posttranscriptional splicing, coupling
with transcription can be determinant for AS regulation.
Sincepre-mRNAsplicingisamultistepreaction,itispossible
that commitment to splicing takes place cotranscriptionally
during early splice-site recognition, while completion of the
splicing reaction occurs posttranscriptionally [20, 28, 29],
consistent with the fact that introns are not necessarily
removed in the exact order that they are transcribed [17, 30–
32]. This mechanism, which can be viewed as a cotranscrip-
tional commitment rather than a cotranscriptional catalysis,
tends to apply largely to splicing and not to other RNA-
processing events like capping and cleavage/polyadenylation
[33–37]. Intermediate scenarios are also possible, with both
splicing commitment and catalysis taking place cotranscrip-
tionally but not following a strict 5 to 3 direction of intron
removal [10, 38].
Another implication of cotranscriptional splicing is that
it allows for a bidirectional coupling of the two processes
[1, 20, 39, 40]. For instance, the splicing machinery can
reciprocally aﬀect transcription in diﬀerent ways by either
stimulating transcriptional elongation [41, 42], transcrip-
tional initiation [43, 44] and, as recently shown in yeast,
by imposing a transient pausing checkpoint around the
3 end of introns and on terminal exons [45, 46]. This
bidirectional feedback might in turn reinforce splicing eﬃ-
ciency, conferring important advantages for gene expression.
Nevertheless, reciprocal coupling might not be a widespread
general phenomenon considering that elongation kinetics
seems to be independent of splicing in some model genes
[47]. This highlights the possibility that speciﬁc exon-intron
architectures and/or cis-acting sequences might be required
for reciprocal coupling to occur.
Despite all the seemingly clear advantages of cotran-
scriptional over posttranscriptional splicing, particularly in
allowing for coupling, the true proportions of these two
modes of splicing in mammals still await to be determined
on a genome-wide scale. It will be interesting to use global
approaches to answer this question, which might have
profound implications in reorienting our current research
and on our understanding of the regulation of AS.
3.EarlyDiscoveries
In our current view, the regulation of AS is the result of
the combined action of splicing factors acting on splicing
enhancers and silencers, regulatory secondary structure
motifs of mRNAs, and the coupling with RNA polymerase
II (Pol II) transcription [22, 48–51]. An early indication
for coupling was the ﬁnding that promoter identity aﬀects
splicing decisions independently of the strength of the
promoter, opposing the classical view whereby promoters
are limited to aﬀect transcription levels ([52–56], for review,
see [57]). Diﬀerent promoters, such as those of the α-globin
and ﬁbronectin (FN) genes, were shown to induce a 10-
fold diﬀerence in inclusion of the human FN alternative
exon 33 (E33, also referred to as EDI or EDA) when
driving its expression from reporter minigenes in transiently
transfected mammalian cells [52, 53]( Figure 1).
One implication of the promoter eﬀect on AS is that
splicing factors could regulate AS through promoters. Cell-
speciﬁc AS events could then arise from cell-speciﬁc pro-
moter occupation rather than from the diﬀerential abun-
dance of ubiquitous splicing factors. Under physiological
conditions, promoter architecture could then control AS
throughthediﬀerentialoccupationbydiﬀerenttranscription
factors. Supporting this hypothesis, evidence shows that
transcriptional activators and coactivators, with diﬀerent
eﬀects on Pol II, indeed aﬀect AS diﬀerentially [58, 59].
4.The KineticsofCoupling
Transcription appears to inﬂuence pre-mRNA splicing
through at least two independent modes: by kinetically
coupling the processing reactions, where the rate of Pol II
elongation inﬂuences the outcome of the alternative events
[60,61],andbyphysicallyandfunctionallyrecruitingmRNA
processingfactorstothetranscriptionmachinery,inparticu-
lar to Pol II’s carboxyterminal domain (CTD) [13, 62–65]. In
fact, recruitment of splicing factors to sites of transcription is
dependent on RNA Pol II CTD [66] and deletion of the CTD
impairs capping, cleavage/polyadenylation, and splicing of
the b-globin transcript [34]. Here we provide a view of the
kinetic mode of coupling, although accumulated evidence
supports that both modes can operate simultaneously in a
nonmutually exclusive manner (for reviews on the recruit-
ment mode of coupling, see [2, 65, 67]).
It should be pointed out that transcription itself is
a complex multistep and regulated process, organized as
a transcription cycle, with each step subjected to extensive
regulation [68]. However, it is mainly at the elongation step
of transcription where most of the connections betweenGenetics Research International 3
α-gb Strong
3SS
Strong
3SS
Pol II
Weak
3SS
Weak
3SS
FN
Exon
skipping
Exon
inclusion
Pol II
FN-E33
Figure 1: Promoters aﬀect alternative splicing. α-globin/FN hybrid minigenes under the control of diﬀerent promoters, used in transient
transfectionsofmammaliancellsinculturetoassessinclusionlevelsofthealternativelysplicedE33(EDIorEDA)cassetteexon(darkyellow).
Inclusion level with the FN promoter is >10-fold higher when compared to the α-globin promoter.
the transcription and splicing machineries actually occur.
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before the ﬁnding of the promoter eﬀect [69]a n dw a sl a t e r
supported by several lines of evidence. Eperon et al. [69]
showed that, in contrast to in vitro conditions, ongoing RNA
synthesis in vivo aﬀects the potential secondary structure
of long—but not that of short—RNA substrates, which
in turn aﬀects splicing, pointing at a kinetic link between
transcription and splicing. Additional evidence came from
experiments in which RNA Pol II’s local pausing caused
by elements inserted into the tropomyosin gene, promoted
higher inclusion of tropomyosin exon 3 [60]. However,
more conclusive evidence for a role of elongation on AS
regulation was shown in a series of reports demonstrating
that several factors globally impacting Pol II elongation
also aﬀect AS. (i) Replication of AS reporter minigenes
greatly stimulates FN E33 inclusion, and is counteracted
by trichostatin A (TSA), a potent inhibitor of histone
d e a c e t y l a t i o nc o n s i d e r e dt od r i v ec h r o m a t i ni n t oa n“ o p e n ”
state.Thissuggestedthatreplicationconveysamorecompact
chromatin structure to the template, thus slowing elongation
and leading to higher E33 inclusion [70]. (ii) Drugs known
to inhibit elongation, such as DRB [58, 70], ﬂavopiridol, or
camptothecin [38], favor E33 inclusion. (iii) Transcriptional
activation by VP16, a factor that promotes both initiation
and elongation, decreases E33 inclusion while Sp1, acting
only on initiation, has no eﬀect on E33 inclusion [58]. (iv)
The presence of the SV40 transcriptional enhancer near a
promoter stimulates Pol II elongation and provokes a 3–
10-fold reduction in FN E33 inclusion independently of the
promoter used [71]. (v) Slow mutants of RNA Pol II increase
FNE33inclusioninhumancells,aﬀectASoftheendogenous
gene ultrabithorax (Ubx) in Drosophila, and modulate
the inclusion of an artiﬁcially created alternative exon in
yeast [61, 72]. (vi) DNA-damage signaling triggered by UV
irradiation aﬀects the AS of ﬁbronectin, caspase 9, Bcl-x,
and other human genes by inducing hyperphosphorylation
of Pol II CTD and blocking Pol II elongation [73]. These
data are in agreement with a “ﬁrst come, ﬁrst served” model
for regulation of AS [74]( Figure 2). One interpretation
of this model is that slow elongation favors the removal
of the intron upstream of an alternative cassette exon
before removal of the downstream intron. Alternatively, slow
elongation would favor recruitment of splicing factors to the
upstream intron before the downstream intron is synthe-
sized. Once commitment to include the exon is achieved,
the order of intron removal becomes irrelevant (Figure 2).
The latter interpretation is supported by recent evidence
showing a preferential removal of the intron downstream
of the FN cassette exon 33 before the upstream intron
has been removed [38]. Most importantly, whereas cis-
acting mutations and trans-acting factors that upregulate
E33 inclusion alter the relative order of intron removal,
elongation slowdown also induces higher E33 inclusion
withoutaﬀectingtheorderofintronremoval,suggestingthat
slowelongationfavorscommitmenttoexoninclusionduring
spliceosome assembly [38]. In light of these ﬁndings, “ﬁrst
served”wouldnotbeequivalentto“ﬁrstexcised”butto“ﬁrst
committed,” in agreement with the observed preferential
cotranscriptionality of spliceosome recruitment rather than
catalysis. The control of elongation on AS is not restricted to
a few cases. Recent data conﬁrms and extends the ﬁndings of
elongation control on AS using a global approach based on
AS microarray proﬁling [48]. This study demonstrates that a
variety of conditions that impact Pol II elongation, including
drug treatments (DRB and camptothecin), Pol II mutants
that inhibit elongation (slow and CTD phosphorylation Pol
II mutants), and cellular stress (UV irradiation, know to
impact Pol II elongation), globally aﬀect both the mRNA
levels and AS of a signiﬁcant number of the genes. Moreover,
the largest statistically signiﬁcant fraction of aﬀected genes
showed a concomitant decrease in steady-state mRNA levels
with increase in exon inclusion levels, coincident with many
of the examples previously reported [60, 61, 70, 72, 73, 75,
76]. Nevertheless, there was also a smaller but signiﬁcant
number of genes displaying decreased mRNA levels with4 Genetics Research International
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Figure 2: Alternative models for the “ﬁrst come, ﬁrst served” mechanism of splice site selection. (a) Fast elongation promotes usage of the
stronger downstream 3 splice site. (b) Slow elongation causes preferential excision of the upstream intron (ﬁrst served = ﬁrst excised). (c)
Slow elongation causes commitment to E33 inclusion via recruitment of splicing factors (ﬁrst served = ﬁrst committed). Both introns are
excised individually and in an order that is independent of elongation. (Based on [38].)
decreased exon inclusion levels [48], consistent with the idea
that inhibition of Pol II elongation can lead to increased
exon inclusion as well as increased exon skipping depending
on the underlying splicing regulatory mechanism involved
in each case [55, 61]. Pol II’s elongation-dependent changes
in AS regulation also display a high preference to modulate
the expression levels of genes involved in RNA metabolism,
includingpre-mRNAsplicingfactorsandotherRNAbinding
proteins. Interestingly, about one-third of those genes con-
tainASeventsthatintroduceaprematureterminationcodon
(PTC) when spliced into the mature mRNA, subsequently
leading to nonsense-mediated mRNA decay (NMD) [48].
This represents another example of evolutionarily conserved
elongation-coupled events, acting together to coordinate the
levelsorRNAbindingproteinswiththeirsteady-statemRNA
levels.
5. Elongation Links to Chromatin
The promoter eﬀect, together with the kinetic, physical,
and functional coupling modes of transcription and AS,
immediately shifted the attention to other factors thought to
be restricted to transcriptional regulation, such as the chro-
matin structure. It soon became clear that the unanticipated
complexity of splicing regulation could not be explained
solely based on the current models, which lacked a clear
connection to in vivo situations. Chromatin is the natural
substrate upon which transcriptional regulation acts in vivo,
and major discoveries have recently pointed at chromatin
structure and post-translational histone modiﬁcations as key
regulators of AS.
The chromatin role on AS regulation is broad, involving
both direct (elongation-independent) interactions with the
splicing machinery and eﬀects on AS through changes in
transcription elongation. Here, we concentrate on the later,
although recent ﬁndings on the direct roles of chromatin
on splicing have signiﬁcantly changed our view of how
exon-intron architecture is achieved by intimately linking
nucleosome to exon structure ([77–84], for reviews, see [5–
7].Infact,genome-widemappingofnucleosomepositioning
on exons at the DNA level may shed light on one of the most
striking puzzles in the ﬁeld of splicing, that is, how does
the splicing machinery recognizes, with high ﬁdelity, short
exons (on average 150bp) “ﬂoating” in a “sea” of introns
(on average 5.4kbp), an exon-intron architecture typical
of vertebrate genes [85, 86]. Notably, the average size of a
mammalian exon is similar to the length of DNA wrapped
around a nucleosome, suggesting a conserved function for
the nucleosome in exon deﬁnition [79, 80, 82]. According
to the exon deﬁnition model, originally postulated by S. M.
Berget [87], the spliceosome and auxiliary factors achieve
this recognition by preferentially assembling on 3 and 5
sites paired across exons and not across introns (i.e., not
following an intron deﬁnition mode of recognition, typical
in lower eukaryotes like yeast). This favors exon recognition
and acts as a selective force for short exon size. As described
below, nucleosome positioning on exons may help in exon
deﬁnition by creating roadblocks for Pol II elongation thatGenetics Research International 5
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Figure 3: Chromatin couples elongation to alternative splicing. (a) Early evidence for a role of chromatin on splicing: replication aﬀects
alternativesplicing.Loosenucleosomeassembly(asintransientlytransfectedreporterminigenes)givesrisetolowinclusionofthealternative
exon(yellow)intothematuremRNA.Afterreplication,nucleosomeorganizationbecomesmorecompact,promotingmuchhigherinclusion
of the alternative exon. (b) Depolarization of neuronal cells or treatment with TSA triggers intragenic histone acetylation and looser
nucleosome compaction which in turn causes skipping of the alternative exon (yellow). (c) Model for TGS-AS. Transfection with siRNAs
targeting the intron downstream from the alternative exon (yellow) promotes dimethylation and trimethylation of H3K9 and H3K27 (green
and blue marks, resp.), triggered by siRNA’s guide strand entering a silencing complex containing AGO1. HP1α is recruited and the resulting
condensed chromatin structure generates roadblocks to Pol II elongation, causing higher inclusion of the alternative exon according to the
kinetic coupling model.
provide longer time for cotranscriptional recognition of
splice sites in the nascent pre-mRNA.
6.ChromatinStructureinCoupling
A role for chromatin in the coupling of elongation with AS
was ﬁrst suggested with the ﬁnding that two copies of the
same adenovirus genome, either unreplicated or replicated
in the same nucleus, gave rise to diﬀerent alternatively
spliced RNAs [57]. It was then speculated that the chromatin
organization acquired after replication was more compact,
with a subsequent reduction in Pol II elongation rates and
more time to assemble splicing complexes at a suboptimal
upstream 5 splice site, thus favoring its use compared
to the downstream 5 splice site. This was conﬁrmed
by the ﬁnding that FN E33 inclusion is sensitive to the
replication-mediated chromatinization status of the reporter
plasmid [58, 70]( Figure 3(a). See above). Both in plants
and humans genes, RNA Pol II distribution correlates with
nucleosome deposition with preferential accumulation at
exons relative to introns [79, 80, 83, 88], consistent with
nucleosomes acting as barriers that locally modulate RNA
Pol II density by inducing its pausing [89, 90]. This could
in turn modulate splicing eﬃciency, in agreement with RNA
Pol II being more highly enriched at alternatively spliced
exons than at constitutive ones [88]. Nucleosome density
also varies according to splice site strength, with stronger
positioning of nucleosomes in included alternatively spliced
exons than excluded ones [80] and stronger positioning at
exons deﬁned by weaker splice sites [81, 82]. Consistent
with these results, overexpression of the ATPase-dependent
chromatin-remodeling complex SWI/SNF subunit Brm in
human cells, induces accumulation of Pol II with a modiﬁed
CTD phosphorylation pattern on regions encoding variant
exons of the CD44 gene and causes increased inclusion of
these exons into mature mRNA [91].
7. HistoneModiﬁcations inCoupling
Histone modiﬁcations have emerged as major regulators of
AS by either impacting the coupling of elongation with AS
or by direct means such as recruiting splicing factors to the
nascent pre-mRNA [7]. An indication for a role of histone
modiﬁcations in the coupling of elongation with AS was the
observation that treatment of cells with the histone deacety-
lase inhibitor TSA induces skipping of the alternatively6 Genetics Research International
splicedﬁbronectinE33andtheneuralcelladhesionmolecule
(NCAM) exon 18 [58, 75, 76]. In a more physiological
context, depolarization of neuronal cells increases H3K9
acetylation and H3K36 methylation locally around the
alternatively spliced exon 18 of NCAM which correlates with
increased exon skipping [76]( Figure 3(b)). Interestingly,
no changes in histone acetylation were observed at the
NCAM promoter, suggesting that this reversible eﬀect may
be due to an intragenic and local modulation of the
RNA Pol II elongation rate [76]. For instance, acetylated
and open chromatin would induce fast Pol II elongation
and skipping of the alternative exon. In line with these
observations, targeting of an intronic sequence downstream
of the alternatively spliced E33 of ﬁbronectin with small
interfering RNAs induces local heterochromatinization and
increased E33 inclusion without changes in general tran-
scription levels [75]( Figure 3(c)). In addition, inhibition of
histonedeacetylation,DNAmethylation,H3K9methylation,
and downregulation of heterochromatin protein 1α (HP1α)
abolish the siRNA-mediated eﬀect on exon E33 splicing [75],
suggesting a role of these modiﬁcations in AS regulation.
Considering the multiple evidence for the involvement of
chromatin in siRNA eﬀects on splicing, this mechanism
has been referred to as TGS-AS for transcriptional gene-
silencing-regulated AS [92]( Figure 3(c)).
Several other epigenetic modiﬁcations, including DNA
methylation, may also directly or indirectly act via histone
modiﬁcations to aﬀect splice site decisions [83, 93, 94]. This
adds to the additional mechanism involving direct physical
crosstalk between chromatin and the splicing machinery via
an adaptor complex [7, 95, 96].
8. Conclusions and Outlook
The fact that transcriptional elongation is largely connected
to pre-mRNA processing and particularly to AS regulation
has boosted extensive eﬀorts to understand its mechanisms
and physiological implications. The link to chromatin seems
to be the natural way in which elongation and splicing
are truly engaged and might indeed explain the poorly
understood mechanisms by which tissue- and cell-type-
speciﬁc AS patterns are established, propagated, and main-
tained. Although some cell- and tissue-speciﬁc diﬀerences in
expression of constitutive splicing factors have been reported
[97],itistemptingtospeculatethat,inanalogytothehistone
code mechanisms used to specify gene expression, a histone-
basedsystemmayalsoencodeinformationthatspeciﬁescell-
and tissue-speciﬁc AS patterns. As recently proposed, this
would provide an epigenetic memory for splicing decisions
likely to be heritable during proliferation and susceptible
to modiﬁcation along diﬀerentiation, without the need for
major changes in the AS rules at each step of diﬀerentiation
[7]. Nevertheless, it still remains to be determined whether
the eﬀects of histone modiﬁcation on RNA processing are
heritable and therefore authentic epigenetic modiﬁcations or
whether they are just transient modulators.
Given the bidirectional nature of coupling, it is conceiv-
able that splicing might reciprocally feed back on the chro-
matin structure via aﬀecting the transcription machinery. In
fact,besidesrecruitingsplicingregulatorssuchasSRproteins
or U2 snRNP subunits [25, 64], Pol II can interact with
histone modiﬁers such as the histone 3 lysine 36 (H3K36)
methyltransferase Set2 [98], known, for example, to regulate
histone deacetylation and prevent inappropriate initiation
within the body of transcribed genes [99]. This interesting
possibility would build up on the notion that transcription,
chromatin, and splicing are intimately dependent on each
other.
Future directions of the ﬁeld will most likely aim at
a more comprehensive view on the histone modiﬁcations
role in AS. Histone modiﬁcations must be comprehensively
mapped on a genome-wide scale in multiple cell types and
tissues and compared to global AS patterns. New candidate
players will be most likely be studied, such as noncoding
RNAs recently shown to be involved in heterochromatin
structure and associated with AS regulation [100, 101]. Ulti-
mately, a better understanding of the multiple links between
transcription and splicing will head the way to decipher
the complexity of gene expression both in physiological and
pathological conditions.
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